Next Article in Journal
Glomangioma Supply from Profunda Femoris Artery in Peripheral Artery Disease
Next Article in Special Issue
Role of Interferons in Mycobacterium tuberculosis Infection
Previous Article in Journal
Efficacy of Naproxen/Fexofenadine (SJP-003) in the Prevention of Side Effects of Influenza Vaccination: Four Case Studies
 
 
Review

Review of Pediatric Tuberculosis in the Aftermath of COVID-19

College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91710, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Ulrich Sack
Clin. Pract. 2022, 12(5), 738-754; https://doi.org/10.3390/clinpract12050077
Received: 18 August 2022 / Revised: 6 September 2022 / Accepted: 8 September 2022 / Published: 11 September 2022
(This article belongs to the Special Issue Novel Therapies against Mycobacterium tuberculosis)
In 2014, the World Health Organization developed the End Tuberculosis Strategy with the goal of a 95% reduction in deaths from tuberculosis (TB) by 2035. The start of the COVID-19 pandemic and global lockdown has had a major impact on TB awareness, screening, diagnosis, and prompt initiation of treatment, inevitably leading to a significant setback. We explore pediatric tuberculosis through the lens of the COVID-19 era, investigating how COVID-19 has impacted pediatric TB cases in different regions of the world and what the implications are for management moving forward to mitigate these effects. Furthermore, in light of recent findings showing how exposed infants and children are at higher risk than we thought of contracting the disease, greater attention and resources are needed to prevent further downward trends. View Full-Text
Keywords: tuberculosis; pediatrics; COVID-19; SARS-CoV-2; immunology; prevention tuberculosis; pediatrics; COVID-19; SARS-CoV-2; immunology; prevention
Show Figures

Figure 1

MDPI and ACS Style

Rangchaikul, P.; Ahn, P.; Nguyen, M.; Zhong, V.; Venketaraman, V. Review of Pediatric Tuberculosis in the Aftermath of COVID-19. Clin. Pract. 2022, 12, 738-754. https://doi.org/10.3390/clinpract12050077

AMA Style

Rangchaikul P, Ahn P, Nguyen M, Zhong V, Venketaraman V. Review of Pediatric Tuberculosis in the Aftermath of COVID-19. Clinics and Practice. 2022; 12(5):738-754. https://doi.org/10.3390/clinpract12050077

Chicago/Turabian Style

Rangchaikul, Patrida, Phillip Ahn, Michelle Nguyen, Vivian Zhong, and Vishwanath Venketaraman. 2022. "Review of Pediatric Tuberculosis in the Aftermath of COVID-19" Clinics and Practice 12, no. 5: 738-754. https://doi.org/10.3390/clinpract12050077

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop